{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:28:37Z","timestamp":1786595317031,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>To date, evidence suggesting the optimal timing of antibody testing in human T-cell lymphotropic virus type 1 (HTLV-1)-exposed infants is lacking. Testing HTLV-1-exposed infants must balance the need for repeat testing if done too early while minimizing loss to follow-up with protracted follow-up intervals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Single-center, retrospective cohort analysis of HTLV-1 serologic testing and breastfeeding practices in infants born to HTLV-1 seropositive pregnant individuals between 01\/01\/2016 and 10\/03\/2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Nineteen children were identified, of whom 5 had positive serological tests for HTLV-1 when first tested, and 14 were seronegative on the first sample, with a median age at first negative test of 18.4 months (95% confidence interval: 6.9). None have been confirmed infected. Six children were known to have breast\/chest-fed for an average of 4.5 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Serologic testing of HTLV-1-exposed infants can be done at 18 months, minimizing persistent transplacental positives and follow-up attrition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005371","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:00:25Z","timestamp":1786593625000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Timing of Loss of Transplacental Antibodies in Infants Born to Mothers Living With Human T-cell Lymphotropic Virus Type 1"],"prefix":"10.1097","author":[{"given":"Justin","family":"Penner","sequence":"first","affiliation":[{"name":"Department of Paediatric Infectious Diseases, Imperial College Healthcare NHS Trust, London, United Kingdom"},{"name":"Department of Infectious Disease, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Poletti de Chaurand","sequence":"additional","affiliation":[{"name":"Division of Obstetrics, Foundation IRCCS San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Seery","sequence":"additional","affiliation":[{"name":"Department of Paediatric Infectious Diseases, Imperial College Healthcare NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Burkhardt","sequence":"additional","affiliation":[{"name":"Department of Paediatric Infectious Diseases, Imperial College Healthcare NHS Trust, London, United Kingdom"},{"name":"Division of Paediatric Infectious Diseases, Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Rosadas","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Greiller","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Randell","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases and Microbiology, Imperial College Healthcare NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermione","family":"Lyall","sequence":"additional","affiliation":[{"name":"Department of Paediatric Infectious Diseases, Imperial College Healthcare NHS Trust, London, United Kingdom"},{"name":"Department of Infectious Disease, Imperial College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Imperial College London, London, United Kingdom"},{"name":"National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"R1-20260813","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.3390\/microorganisms10112227","article-title":"Current interventions to prevent HTLV-1 mother-to-child transmission and their effectiveness: a systematic review and meta-analysis.","volume":"10","author":"Rosadas","year":"2022","journal-title":"Microorganisms"},{"key":"R2-20260813","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1473-3099(19)30402-5","article-title":"Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies.","volume":"20","author":"Schierhout","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R3-20260813","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/INF.0b013e31827efc39","article-title":"Mother-to-child transmission of human T-cell lymphotropic virus type 1.","volume":"32","author":"Moriuchi","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20260813","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.3390\/ijms24086961","article-title":"How can we prevent mother-to-child transmission of HTLV-1?","volume":"24","author":"Itabashi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R5-20260813","first-page":"100888","article-title":"Brazil takes a leap towards the elimination of HTLV-1 vertical transmission.","volume":"39","author":"Rosadas","year":"2024","journal-title":"Lancet Reg Health Am"},{"key":"R7-20260813","doi-asserted-by":"crossref","first-page":"941647","DOI":"10.3389\/fmed.2022.941647","article-title":"A review of the prevention of mother-to-child transmission of human T-cell lymphotrophic virus type 1 (HTLV-1) with a proposed management algorithm.","volume":"9","author":"Barr","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R8-20260813","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ijc.2910490508","article-title":"Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. The mother-to-child transmission study group.","volume":"49","author":"Takahashi","year":"1991","journal-title":"Int J Cancer"},{"key":"R9-20260813","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ijc.2910400607","article-title":"Mother-to-child transmission of human T-cell leukemia virus type I (HTLV-I): a fifteen-year follow-up study in Okinawa, Japan.","volume":"40","author":"Kusuhara","year":"1987","journal-title":"Int J Cancer"},{"key":"R10-20260813","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00042560-199606010-00013","article-title":"Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I\/II) in Gabon: a prospective follow-up of 4 years.","volume":"12","author":"Nyambi","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R11-20260813","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/infdis\/jiaf064","article-title":"Identification of natural remission of mother-to-child retroviral transmission.","volume":"232","author":"Grover","year":"2025","journal-title":"J Infect Dis"},{"key":"R12-20260813","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/infdis\/jiaf120","article-title":"Identification of occult simian T-cell leukemia virus type 1 infection in Japanese Macaques.","volume":"232","author":"Kidiga","year":"2025","journal-title":"J Infect Dis"},{"key":"R13-20260813","doi-asserted-by":"crossref","first-page":"e0273777","DOI":"10.1371\/journal.pone.0273777","article-title":"The barriers and facilitators of HIV-exposed infant testing as perceived by HIV-positive mothers in Botswana: a qualitative study.","volume":"17","author":"Karugaba","year":"2022","journal-title":"PLoS One"},{"key":"R14-20260813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7204a1","article-title":"CDC Recommendations for hepatitis C testing among perinatally exposed infants and children - United States, 2023.","volume":"72","author":"Panagiotakopoulos","year":"2023","journal-title":"MMWR Recomm Rep"},{"key":"R15-20260813","first-page":"507","article-title":"Psychosocial impact of false-positive newborn screening results: a scoping review.","volume":"11","author":"Chudleigh","year":"2024","journal-title":"Children (Basel)"},{"key":"R16-20260813","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12887-017-0873-1","article-title":"Healthcare professionals\u2019 and parents\u2019 experiences of the confirmatory testing period: a qualitative study of the UK expanded newborn screening pilot.","volume":"17","author":"Moody","year":"2017","journal-title":"BMC Pediatr"},{"key":"R17-20260813","doi-asserted-by":"crossref","first-page":"e25209","DOI":"10.1002\/jia2.25209","article-title":"Attrition of HIV-exposed infants from early infant diagnosis services in low- and middle-income countries: a systematic review and meta-analysis.","volume":"21","author":"Carlucci","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"R18-20260813","doi-asserted-by":"crossref","first-page":"e2023064745","DOI":"10.1542\/peds.2023-064745","article-title":"Factors associated with perinatal hepatitis C screening among exposed children: 2016-2020.","volume":"154","author":"Kuncio","year":"2024","journal-title":"Pediatrics"},{"key":"R19-20260813","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/pch\/pxaf012","article-title":"Hepatitis C virus testing in infants, a move to early screening by HCV RNA at 2 months of age.","volume":"30","author":"Biondi","year":"2025","journal-title":"Paediatr Child Health"},{"issue":"Suppl 2","key":"R20-20260813","first-page":"S3","article-title":"Lessons learned from family-centred models of treatment for children living with HIV: current approaches and future directions.","volume":"13","author":"Leeper","year":"2010","journal-title":"J Int AIDS Soc"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:00:27Z","timestamp":1786593627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005371","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}